Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000801958 | SCV000941764 | benign | Nemaline myopathy 2 | 2024-01-29 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001580548 | SCV001817512 | uncertain significance | not provided | 2022-01-22 | criteria provided, single submitter | clinical testing | In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; Has not been previously published as pathogenic or benign to our knowledge |
Revvity Omics, |
RCV001580548 | SCV003811610 | uncertain significance | not provided | 2021-10-27 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV000801958 | SCV001461670 | uncertain significance | Nemaline myopathy 2 | 2020-01-17 | no assertion criteria provided | clinical testing |